ADAPTIVE BIOTECHNOLOGIES CORP

Profile

Company Names

ADAPTIVE BIOTECHNOLOGIES CORP
ADAPTIVE TCR CORP

Addresses

1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA 98102

1551 EASTLAKE AVENUE EAST STE. 200, SEATTLE, WA 98102

1551 EASTLAKE AVENUE EAST, SUITE 200, SEATTLE, WA 98102

307 WESTLAKE AVENUE NORTH, SEATTLE, WA 98109

C/0 BYRON DAILEY 701 FIFTH AVENUE, SUITE 7000, SEATTLE, WA 98104

Phone Numbers

206-659-0067
312-805-0047
206-659-0440

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2009

State Incorporated:

WASHINGTON

Total Amount Raised:

$413,300,022.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2015-05-05 
$195,099,954.00 
$195,099,954.00 
$0.00 
Equity 
6
2015-01-07 
$93,750,000.00 
$93,750,000.00 
$0.00 
Equity 
5
2014-04-04 
$106,999,480.00 
$106,999,480.00 
$0.00 
Equity 
4
2013-07-01 
$5,024,792.00 
$19,999,997.00 
$14,975,205.00 
Equity 
3
2012-06-07 
$2,649,272.00 
$5,048,707.00 
$2,399,435.00 
Equity 
2
2011-05-20 
$5,821,524.00 
$7,500,000.00 
$1,678,476.00 
Equity 
1
2009-12-17 
$3,955,000.00 
$5,000,000.00 
$1,045,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHAD 
 
COHEN 
DIRECTOR
KATHLEEN 
 
DETERMANN 
EXECUTIVE OFFICER
ROB 
 
HERSHBERG 
DIRECTOR
PETER 
 
NEUPERT 
DIRECTOR
CHAD 
 
ROBINS 
EXECUTIVE OFFICER, DIRECTOR
HARLAN 
 
ROBINS 
EXECUTIVE OFFICER, DIRECTOR
DEAN 
 
SCHORNO 
EXECUTIVE OFFICER
JOHN 
 
STUELPNAGEL 
DIRECTOR
CRAIG 
 
WEISSMAN 
DIRECTOR
TOM 
 
WILLIS 
DIRECTOR
ANDRIS 
 
ZOLTNERS 
DIRECTOR
ANDY 
 
ZOLTNERS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-01 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-07 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-20 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#